The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Impact of Obesity on the Risk for Polycystic Ovary Syndrome
Open accessAbstract
CONTEXT: Although it is well established that adiposity increases the severity of the clinical features of polycystic ovary syndrome (PCOS), the data regarding the prevalence of PCOS in obese women and the change in body weight women presented with PCOS over time are scarce. OBJECTIVE: The objective of the study was to determine whether obesity increases the risk of PCOS and whether the degree of obesity of PCOS patients has increased, paralleling the rise in obesity in the population. DESIGN: We analyzed data from two consecutive populational studies assessing the prevalence of PCOS and a database containing all untreated PCOS patients evaluated at a university clinic between 1987 and 2002. SETTING: The study was conducted at a tertiary care center. PATIENTS OR OTHER PARTICIPANTS: Participants included 675 women who participated in prevalence studies and 746 PCOS patients. MAIN OUTCOME MEASURES: Populational prevalence of PCOS according to body mass index (BMI) and change in BMI of PCOS patients over time were measured. RESULTS: The prevalence rates of PCOS in underweight, normal-weight, overweight, and obese women were 8.2, 9.8, 9.9, and 9.0%, respectively. Prevalence rates reached 12.4 and 11.5% in women with BMI 35-40 kg/m2 and greater than 40 kg/m2 (P = NS). The mean BMI of PCOS patients diagnosed between 1987 and 2002 rose, beginning in 1997 and reaching 37.3 +/- 9.9 kg/m2 in 2000-2002, paralleling the change in BMI of the surrounding population (10-14% obesity rate in 1987, 15-19% in 1997, and 25% or greater in 2002). CONCLUSION: Our results suggest that the risk of PCOS is only minimally increased with obesity, although the degree of obesity of PCOS patients has increased, similar to that observed in the general population. These data indicate that obesity in PCOS reflects environmental factors to a great extent.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“despite PCOS being prevalent across body sizes [18,46].”
From Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS) (2023) · cites this paper as [46]
Citations
Cites
(2000) · PubMed · Cited by 13,173
Obesity : Preventing and managing the global epidemic
Akram, D. S., Astrup, A. V., Atinmo, T., Boissin, J.-L., Bray, G. A., Carroll, K. N., Chitson, P., Chen, C., Dietz, W. H., Hill, J. O., et al. (2000) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 12,945
Wang, Y., & Beydoun, M. A. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm007 · Cited by 2,854
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Self-citationKnochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,760
Self-citationAsunción, M., Calvo, R. M., Millán, J. L. S., Sancho, J., Ávila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,328
Knochenhauer, E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3078 · Cited by 1,134
Self-citationAndrogen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132
Self-citationDiamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6148 · Cited by 1,107
Andrology: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients
Balen, A. H., Conway, G. S., Kaltsas, G., Techatraisak, K., Manning, P. J., West, C., & Jacobs, H. S. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136243 · Cited by 1,060
Flagged first, then by citations
1 of the 46 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 401
Kominiarek, M. A., Jungheim, E. S., Hoeger, K. M., Rogers, A. M., Kahan, S. I., & Kim, J. J. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.02.006 · Cited by 50
Kataoka, J., Larsson, I., Björkman, S., Eliasson, B., Schmidt, J., & Stener‐Victorin, E. (2019) · Clinical Endocrinology · doi:10.1111/cen.14098 · Cited by 48
Effect of body mass index on clinical manifestations in patients with polycystic ovary syndrome
Tamimi, W. G., Siddiqui, I., Tamim, H., AlEisa, N., & Adham, M. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.06.003 · Cited by 46
Obesity in midlife: lifestyle and dietary strategies
Khandelwal, S. (2019) · Climacteric · doi:10.1080/13697137.2019.1660638 · Cited by 48
Do women with PCOS have a unique predisposition to obesity?
Hoeger, K. M., & Oberfield, S. E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.026 · Cited by 45
Celik, C., Abalı, R., Baştu, E., Taşdemir, N., Tasdemir, U. G., & Gul, A. (2013) · Human Reproduction · doi:10.1093/humrep/det002 · Cited by 46
Tehrani, H. G., Allahdadian, M., Zarre, F., Ranjbar, H., & Allahdadian, F. (2017) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_67_15 · Cited by 45
Vanky, E., Hanem, L. G. E., & Abbott, D. H. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.03.015 · Cited by 44
Hasan, M., Sultana, S., Sohan, M., Parvin, S., Rahman, M. A., Hossain, M. J., Rahman, M. S., & Islam, M. R. (2022) · PLOS ONE · doi:10.1371/journal.pone.0270102 · Cited by 45
Varlamov, O., Chu, M. P., McGee, W., Cameron, J., O'Rourke, R., Meyer, K. A., Bishop, C., Stouffer, R., & Roberts, C. (2013) · Endocrinology · doi:10.1210/en.2013-1428 · Cited by 43
Cardiometabolic Risk in Polycystic Ovary Syndrome
Cooney, L. G., & Dokras, A. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.11.001 · Cited by 50
Polycystic Ovary Syndrome Is Associated with an Increased Prevalence of Irritable Bowel Syndrome
Mathur, R., Ko, A., Hwang, L. J., Low, K., Azziz, R., & Pimentel, M. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0890-5 · Cited by 44
Self-citationPolycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J., & Dumesic, D. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00021-4 · Cited by 41
Harris, H. R., Cushing‐Haugen, K. L., Webb, P. M., Nagle, C. M., Jordan, S. J., Australian Ovarian Cancer Study Group, Risch, H. A., Rossing, M. A., Doherty, J. A., Goodman, M. T., et al. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz113 · Cited by 42
Gestational Weight Gain in Women With Polycystic Ovary Syndrome: A Controlled Study
Kent, J., Dodson, W. C., Kunselman, A. R., Pauli, J. M., Stone, A., Diamond, M. P., Coutifaris, C., Schlaff, W. D., Alvero, R. J., Casson, P. R., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02764 · Cited by 41
Zhang, X., Xu, X., Li, P., Zhou, F., Kong, L., Qiu, J., Yuan, Z., & Tan, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00821 · Cited by 41
Blackshaw, L. C. D., Chhour, I., Stepto, N. K., & Lim, S. S. (2019) · Medical Sciences · doi:10.3390/medsci7070076 · Cited by 40
PCOS in Adolescence and Type 2 Diabetes
Carreau, A.-M., & Baillargeon, J.-P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-014-0564-3 · Cited by 40
Pradas, I., Rovira‐Llopis, S., Naudí, A., Bañuls, C., Rocha, M., Hernández‐Mijares, A., Pamplona, R., Víctor, V. M., & Jové, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-52263-w · Cited by 41
Prevalence and ultrasound features of polycystic ovaries in young unmarried Saudi females
Guraya, S. (2013) · Journal of Microscopy and Ultrastructure · doi:10.1016/j.jmau.2013.06.002 · Cited by 40
Esfahanian, F., Zamani, M. M., Heshmat, R., & Moini nia, F. (2013) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2012.02051.x · Cited by 38
Rondanelli, M., Perna, S., Faliva, M. A., Monteferrario, F., Repaci, E., & Allieri, F. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3433-z · Cited by 44
Evolutionary determinants of polycystic ovary syndrome: part 1
Ünlütürk, U., Sezgın, E., & Yıldız, B. O. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.010 · Cited by 36
Ee, C., Smith, C., Moran, L., MacMillan, F., Costello, M., Baylock, B., & Teede, H. (2020) · BMC Women's Health · doi:10.1186/s12905-020-01090-7 · Cited by 35
Amiri, M., Hatoum, S., Hopkins, D., Buyalos, R. P., Ezeh, U. I., Pace, L. A., Bril, F., Sheidaei, A., & Azziz, R. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae488 · Cited by 35
Self-citationTargeting insulin sensitivity in the treatment of polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903190699 · Cited by 35
The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women
Valderhaug, T. G., Hertel, J. K., Nordstrand, N., Dale, P. O., Hofsø, D., & Hjelmesaeth, J. S. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0040-5 · Cited by 35
Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin
Feng, W., Jia, Y., Zhang, D., & Shi, H.-R. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1101441 · Cited by 34
Batarfi, A. A., Filimban, N., Bajouh, O. S., Dallol, A., Chaudhary, A., & Bakhashab, S. (2019) · BMC Medical Genetics · doi:10.1186/s12881-019-0876-x · Cited by 34
Interaction between common variants of FTO and MC4R is associated with risk of PCOS
Yuan, H., Zhu, G., Wang, F., Wang, X., Guo, H., & Shen, M. (2015) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-015-0050-z · Cited by 33
Clinical Definition of Overweight and Obesity
Garvey, W. T. (2018) · Springer eBooks · doi:10.1007/978-3-319-95655-8_7 · Cited by 36
Lyu, X., Lyu, T., Wang, X., Zhu, H., Pan, H., Wang, L., Yang, H., & Gong, F. (2021) · International Journal of Endocrinology · doi:10.1155/2021/6616693 · Cited by 33
Weight management strategies for patients with PCOS: current perspectives
Ozgen Saydam, B., & Yildiz, B. O. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1896966 · Cited by 33
Clinical and Metabolic Features of Polycystic Ovary Syndrome among Chinese Adolescents
Li, L., Chen, X., He, Z., Zhao, X., Huang, L., & Yang, D. (2012) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2012.07.006 · Cited by 33
Obesity and polycystic ovary syndrome: association with androgens, leptin and its genotypes
Pusalkar, M., Meherji, P. K., Gokral, J., Savardekar, L., Chinnaraj, S., & Maitra, A. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487586 · Cited by 33
Bai, L., Wang, W., Yu, X., Wang, S., Wan, S., & Zhu, Y. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.11.005 · Cited by 33
Marino, J. S., Iler, J., Dowling, A. R., Chua, S. C., Brüning, J. C., Coppari, R., & Hill, J. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048643 · Cited by 31
Diamanti‐Kandarakis, E., & Christakou, C. D. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_4 · Cited by 32
Wei, H., Young, R., Kuo, I.-L., Liaw, C., Chiang, H., & Yeh, C. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.168 · Cited by 31
Chiu, W.-L., Boyle, J. A., Vincent, A. J., Teede, H. J., & Moran, L. (2016) · Neuroendocrinology · doi:10.1159/000455233 · Cited by 31
Cognitive-Behavior Therapy for Children and Adolescents
Szigethy, E., Weisz, J. R., & Findling, R. L. (2012) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370955 · Cited by 31
Covington, J. D., Bajpeyi, S., Moro, C., Tchoukalova, Y. D., Ebenezer, P. J., Burk, D. H., Ravussin, É., & Redman, L. M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0492 · Cited by 29
Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome
Zore, T., Lizneva, D., Brakta, S., Walker, W., Сутурина, Л. В., & Azziz, R. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.10.020 · Cited by 29
Self-citationEffects of androgen and leptin on behavioral and cellular responses in female rats
Feng, Y., Shao, R., Weijdegård, B., Wang, T., Johansson, J., Sun, S., Wang, W., Egecioglu, E., Billig, H., & Stener‐Victorin, E. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.07.012 · Cited by 29
Lazaridou, S., Dinas, K., & Tziomalos, K. (2017) · HORMONES · doi:10.14310/horm.2002.1757 · Cited by 27
Can adipokine visfatin be a novel marker of pregnancy‐related disorders in women with obesity?
Wnuk, A., Stangret, A., Wątroba, M., Platek, A. E., Skoda, M., Cendrowski, K., Sawicki, W., & Szukiewicz, D. (2020) · Obesity Reviews · doi:10.1111/obr.13022 · Cited by 32
Hu, X., Chen, Y., Shen, Y., Zhou, S., Fei, W., Yang, Y., & Que, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1025267 · Cited by 30
Soca, P. E. M., & Peña, A. N. (2009) · Acimed · Cited by 28
He, S., Li, H., Zhang, Q., Zhao, W., Li, W., Dai, C., Li, B., Cheng, J., Wu, S., Zhou, Z., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155456 · Cited by 29
Dwivedi, A. K., Vishwakarma, D., Dubey, P., & Reddy, S. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad067 · Cited by 27
Etrusco, A., Mikuš, M., D’Amato, A., Barra, F., Planinić, P., Goluža, T., Buzzaccarini, G., Marušić, J., Tešanović, M., & Laganà, A. S. (2024) · Biomedicines · doi:10.3390/biomedicines12030653 · Cited by 28
The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
Anala, A. D., Saifudeen, I. S. H., Ibrahim, M., Nanda, M., Naaz, N., & Atkin, S. L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144575 · Cited by 33
Witchel, S. F., Recabarren, S. E., González, F., Diamanti‐Kandarakis, E., Cheang, K. I., Dulęba, A. J., Legro, R. S., Homburg, R., Pasquali, R., Løbo, R. A., et al. (2012) · Endocrine · doi:10.1007/s12020-012-9701-4 · Cited by 26
Chapter 3. Culturally Diverse Children and Adolescents
Ford‐Paz, R. E., & Iwamasa, G. Y. (2012) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370955.es03 · Cited by 26
Jakubowski, K., Black, J. J., Nokali, N. E. E., Belendiuk, K. A., Hannon, T. S., Arslanian, S. A., & Rofey, D. L. (2012) · Journal of Obesity · doi:10.1155/2012/298067 · Cited by 25
Prevalence of polycystic ovary syndrome in a metabolically healthy obese population
Mu, L., Zhao, Y., Li, R., Lai, Y., Chang, H.-M., & Qiao, J. (2019) · International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · doi:10.1002/ijgo.12824 · Cited by 18
Ye, Z.-R., Yan, C., Liao, N., & Wen, S.-H. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01222-y · Cited by 26
Przybycień, P., Gąsior‐Perczak, D., & Placha, W. (2022) · Cells · doi:10.3390/cells11162569 · Cited by 26
Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
Gateva, A., & Kamenov, Z. A. (2012) · Obstetrics and Gynecology International · doi:10.1155/2012/306347 · Cited by 23
Nehra, J., Kaushal, J., Singhal, S. R., & Ghalaut, V. S. (2017) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2017v9i4.16359 · Cited by 23
Apoptosis in polycystic ovary syndrome: Mechanisms and therapeutic implications
Yang, L.-K., Ma, W., Wang, X., Chen, H.-R., Jiang, Y., & Sun, H. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123394 · Cited by 24
Wu, H., Ruan, X., Jin, J., & Mueck, A. O. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1029447 · Cited by 23
Hyperandrogenism Does Not Influence Metabolic Parameters in Adolescent Girls with PCOS
Forrester-Dumont, K., Galescu, O. A., Kolesnikov, A., Raissouni, N., Bhangoo, A., Ten, S., & Suss, A. L. (2012) · International Journal of Endocrinology · doi:10.1155/2012/434830 · Cited by 23
Plaza-Parrochia, F., Bacallao, K., Poblete, C., Gabler, F., Carvajal, R., Romero, C., Valladares, L., & Vega, M. (2014) · Steroids · doi:10.1016/j.steroids.2014.07.008 · Cited by 23
Giblin, K., Kaplan, L. M., Somers, V. K., Le Roux, C. W., Hunter, D. J., Wu, Q., Lalonde, A., Ahmad, N., & Bethel, M. A. (2026) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.70209 · Cited by 34
Duval, K., Langlois, M., Carranza‐Mamane, B., Pesant, M.-H., Hivert, M., Poder, T. G., Lavoie, H. B., Ainmelk, Y., Tribble, D. S., Laredo, S., et al. (2015) · BMC Obesity · doi:10.1186/s40608-015-0077-x · Cited by 22
Singh, S., Akhtar, N., & Ahmad, J. (2012) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.05.013 · Cited by 21
Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome
Τζιόμαλος, Κ., & Dinas, K. D. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00149 · Cited by 24
Dumesic, D. A., Winnett, C., Lu, G., Grogan, T., Abbott, D. H., Naik, R., & Chazenbalk, G. D. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.09.324 · Cited by 20
Liang, P., Xi, L., Shi, J., Li, W., Zhao, S., Deng, Y., Wang, R., Sun, Y., Gu, B., Yuan, L., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.12.029 · Cited by 21
Aromatase Inhibitors for Ovulation and Pregnancy in Polycystic Ovary Syndrome
Eckmann, K. R., & Kockler, D. R. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m096 · Cited by 20
How polycystic ovary syndrome came into its own
Azziz, R. (2021) · F&S Science · doi:10.1016/j.xfss.2020.12.007 · Cited by 19
Self-citationLiu, Y., Xu, Y., Cui, Y., Jiang, S., Diao, F., Liu, J., & Ma, X. (2021) · Neuroendocrinology · doi:10.1159/000521236 · Cited by 19
Polycystic Ovary Syndrome Is a Family Affair
Azziz, R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0477 · Cited by 19
Self-citationLuo, E., Zhang, J., Song, J., Feng, D., Meng, Y., Jiang, H., Li, D., & Fang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.659717 · Cited by 19
Prevalence of hyperandrogenism in Iraqi women with polycystic ovary syndrome
Alsaadi, Y. L., & Mohamad, B. J. (2019) · Iraqi Journal of Science · doi:10.24996/ijs.2019.60.12.8 · Cited by 18
Interventions for the metabolic dysfunction in polycystic ovary syndrome
Bozdag, G., & Yildiz, B. O. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.008 · Cited by 18
Polycystic Ovary Syndrome: Is Obesity a Symptom?
Yıldız, B. O. (2013) · Women s Health · doi:10.2217/whe.13.53 · Cited by 18
An Evolutionary Model for the Ancient Origins of Polycystic Ovary Syndrome
Dumesic, D. A., Abbott, D. H., & Chazenbalk, G. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196120 · Cited by 17
Lete, I., Martínez, A., Lasaga, I., Centurión, E., & Vesga, A. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2301554 · Cited by 18
He, Y., Li, X., Li, Y., Kuai, D., Zhang, H., Wang, Y., & Tian, W. (2024) · Steroids · doi:10.1016/j.steroids.2024.109424 · Cited by 17
Tu, J., Lin, G., Lu, C., & Gong, F. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.860121 · Cited by 17
Chronic anovulation and the polycystic ovary syndrome
KASE, N. G. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.012 · Cited by 16
Epicardial Adipose Tissue—A Novel Therapeutic Target in Obesity Cardiomyopathy
Wiszniewski, K., Grudniewska, A., Szabłowska‐Gadomska, I., Pilichowska‐Paszkiet, E., Zaborska, B., Zgliczyński, W., Dudek, P., Bik, W., Sota, M., & Mrozikiewicz‐Rakowska, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167963 · Cited by 22
Mental and personality disorders in infertile women with polycystic ovary: a case-control study
Ahmadi, M., Faramarzi, M., Basirat, Z., Kheirkhah, F., Chehrazi, M., & Ashabi, F. (2020) · African Health Sciences · doi:10.4314/ahs.v20i3.28 · Cited by 16
Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19
Ilias, Ι., Goulas, S., & Zabulienė, L. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i12.2711 · Cited by 15
Herbert, S., & Woolf, K. (2023) · Nutrients · doi:10.3390/nu15245069 · Cited by 15
“Yet PCOS does affect individuals with different body sizes [18,46].”
BackgroundFrandsen, C. L. B., Svendsen, P. F., Nøhr, B., Viuff, J. H., Maltesen, T., Kjær, S. K., & Jensen, A. (2023) · International Journal of Cancer · doi:10.1002/ijc.34574 · Cited by 15
A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome
Pasquali, R., & Gambineri, A. (2015) · Women s Health · doi:10.2217/whe.15.13 · Cited by 15
Koopman, R. J., Swofford, S., Beard, M. N., & Meadows, S. E. (2009) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2009.01.006 · Cited by 15
Distress response in granulosa cells of women affected by PCOS with or without insulin resistance
Cozzolino, M., Herraiz, S., Çakıroğlu, Y., García-Velasco, J. A., Tıraş, B., Pacheco, A., Rabadán, S., Kohls, G., Barrio, A., Pellicer, A., et al. (2022) · Endocrine · doi:10.1007/s12020-022-03192-8 · Cited by 14
Homa, L. D., Burger, L. L., Cuttitta, A. J., Michele, D. E., & Moenter, S. M. (2015) · Endocrinology · doi:10.1210/en.2015-1593 · Cited by 15
Yavangui, M., Farhadian, M., Barati, S., Mahmoodi, M., & Mosleh, A. B. (2020) · Journal of Reports in Pharmaceutical Sciences · doi:10.4103/jrptps.jrptps_14_19 · Cited by 14
NUCB2 gene polymorphism and its relationship with nesfatin-1 levels in polycystic ovary syndrome
Taşkın, M. İ., Eser, B., Adalı, E., Kara, H., Cuce, C., & Hişmioğulları, A. A. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1081682 · Cited by 14
Maharaj, S., & Amod, A. (2009) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2009.10872199 · Cited by 14
Gourgari, E., Spanakis, E. K., & Dobs, A. S. (2016) · International Journal of Women s Health · doi:10.2147/ijwh.s104825 · Cited by 14
Is Subclinical Hypothyroidism in Patients with Polycystic Ovary Syndrome Associated with BMI?
Yasar, H. (2016) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2016.431 · Cited by 14
Gateva, A., Tsakova, A. D., Hristova, J., & Kamenov, Z. A. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1689550 · Cited by 13
Tian, D., Chen, W., Xu, Q., Li, X., & Lv, Q. (2022) · Minerva Medica · doi:10.23736/s0026-4806.21.07085-3 · Cited by 13
Siddiqui, I., Tamimi, W. G., Tamim, H., AlEisa, N., & Adham, M. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1124-y · Cited by 14
Metadata
- Authors
- Yildiz, B. O., Knochenhauer, E. S., & Azziz, R.
- Affiliations
- Department of Internal Medicine, Endocrinology, and Metabolism Unit (B.O.Y.), Hacettepe University School of Medicine, Hacettepe, 06100 Ankara, Turkey
- Staten Island University Hospital (US)
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Azziz, Ricardo
- ORCID
- Azziz, Ricardo
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-01-01
- Volume
- 93
- Issue
- 1
- Pages
- 162-168
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2190739
- OpenAlex
- W2101492737
- Cited by
- 401
- References
- 46
- Citations by year
- 2026: 7 · 2025: 27 · 2024: 17 · 2023: 23 · 2022: 28 · 2021: 22 · 2020: 21 · 2019: 27 · 2018: 17 · 2017: 21 · 2016: 16 · 2015: 23 · 2014: 24 · 2013: 22 · 2012: 35
- FWCI
- 20.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K24HD001346, R01HD029364, K24 HD 01346, R01-HD29364)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- polycystic ovary syndrome, obesity, body mass index, PCOS prevalence, overweight, environmental factors, adiposity
- MeSH terms
- Adolescent, Adult, Alabama, Androstenedione, Female, Humans, Male, Middle Aged, Obesity, Polycystic Ovary Syndrome, Progesterone, Prolactin, Sex Hormone-Binding Globulin, Testosterone, Thyrotropin, Body Mass Index, Prevalence, Dehydroepiandrosterone Sulfate, 17-alpha-Hydroxyprogesterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
